Ortiz PY, Rodríguez CE

Language: Spanish
References: 21
Page: 1-14
PDF size: 518.14 Kb.

ABSTRACT

Introduction: Lower limb´s peripheral artery disease is a health problem as being the cause of more than 40% of non-traumatic amputations in diabetic and non-diabetic patients. Stem cells could contribute positively to their treatment by participating in the angiogenic process.
Objective: Describe claudication distance and ankle-arm´s pressure index in patients with arterial insufficiency treated with stem cells.
Methods: A quasi-experimental, prospective and analytical study was carried out in 36 patients diagnosed with arterial insufficiency, attended in the Angiology service of "Dr. Carlos J. Finlay" Central Military Hospital. Patients were treated with autologous mononuclear cells obtained from peripheral blood, and they were used intramuscularly. The studied variables were: age, sex, risk factors, occlusive pattern, claudication distance and ankle-arm´s pressure index.
Results: Male sex (63.9%), age group of 65 years and older (44.4%), and white skin (61.1%) predominated. The most common risk factors were: smoking habit (72.2%), and high blood pressure (69.4%). In 77.7% of the cases, the pain while walking disappeared (p < 0.01). The claudication distance increased (p< 0) at the end of the sixth month (397.2 ± 118.8 meters: IC 95 %: 357; 437.4). There was a highly significant increase (p< 0) of the ankle-arm´s pressure index of the dorsalis pedis artery.
Conclusions: Autologous mononuclear cells are effective in treating arterial insufficiency as they eliminate pain during exercise, increase distance while walking, and increase ankle-arm´s pressure rates.

REFERENCES

1. Aboyans V, Ricco JB, Bartelink MLEL, Björck M, Brodmann M, Cohnert T, et al. Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS). Rev Esp Cardiol. 2018;71(2):111.e1-e69. DOI: https://doi.org/10.1016/j.recesp.2017.12.015

2. Kullo IJ, Rooke TW. Peripheral artery disease. N Engl J Med. 2016;374(9):861-71. DOI: http://dx.doi.org/10.1056/NEJMcp1507631

3. Mallagray EP. Claudicación: epidemiología e historia natural. Angiología. 2010; 62:52-6.

4. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation Res. 2015;116(9):1509-26. DOI: http://dx.doi.org/10.1161/circresaha.116.303849

5. Chockalingam A, Thakur JS, Varma S. Evolution of non-communicable diseases: Past, present and future. Intern J Noncomm. Dis. 2017;2(1):1-2.

6. World Health Organization (WHO). World health statistics 2018: monitoring health for the SDGs, sustainable development goals. Geneva: WHO; 2018 [acceso 07/07/2019]. Disponible en: https://apps.who.int/iris/handle/10665/272596

7. Hernández Ramírez P, Dorticós Balea E. Medicina regenerativa: Células madre embrionarias y adultas. Rev Cubana Hematol Inmunol Hemoter. 2004 Dic [acceso 12/02/2020];20(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892004000300001&lng=es

8. Fontaine R, Kieny R, Gangloff JM. Long-term results of restorative arterial surgery in obstructive diseases of the arteries. J Cardiovasc Surg (Torino). 1964;5:463-8.

9. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969;56:676-9.

10. Guo X, Li J, Pang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008;72:605-10. DOI: http://dx.doi.org/10.1253/circj.72.605

11. Cortina Rosales L, Hernández Ramírez P, López De Roux MR, Artaza Sanz HM, Macías Abraham C. Aislamiento de células mononucleares de sangre periférica para trasplante de células madre: Método simplificado. Rev Cubana Hematol Inmunol Hemoter. 2008 Dic [acceso 14/02/2019];24(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892008000300004&lng=es

12. World Medical Association (WMA). Declaration of Helsinki. Ethical principles for medical research involving human subjects. 64th World Medical Association General Assembly. Fortaleza, Brazil, October 2013. Updated Helsinki guidelines for clinical research get mixed reviews. JAMA. 2013. DOI: http://dx.doi.org/10.1001/jama.2013.281053

13. De la Torre Puente C, Triana Mantilla ME, Rodríguez Villalonga LE, Arpajón Peña Y, Almeida Hernández L, Martínez Góngora I. Enfermedades vasculares periféricas y niveles de calidad de vida en el municipio Diez de Octubre. Rev Cubana Angiol y Cir Vasc. 2017 [acceso 30/01/2020];18(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol18_1_17/ang06117.htm

14. Martínez Díaz Y, Fernández Quintana LC, Cabrera Zamora JL, Almeida Hernández L. Calidad de vida en pacientes con enfermedad arterial periférica de miembros inferiores en estadios iniciales. Rev Cubana Angiol y Cir Vasc. 2018 [acceso 30/01/2020];19(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol19_1_18/ang03118.htm

15. Lu H, Daugherty A. Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(3):485-91 DOI: http://dx.doi.org/10.1161/ATVBAHA.115.305380

16. Hernández Ramírez P, Artaza Sánz H, Aparicio Suárez JL, Cruz Tamayo F, Díaz Díaz AJ, Fernández Delgado N, et al. Impacto de la medicina regenerativa en Angiología. Experiencia cubana. Rev Cubana Angiol y Cir Vasc. 2017 [acceso 30/01/2020];18(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol18_1_17/ang02117.htm

17. Feito Castex T, Perurena Llamosa C, Aparicio Suárez JL, Bustillo Santandreu MJ, García Seco F. Implante de células madres hematopoyéticas en pacientes con isquemia crónica de los miembros inferiores. Rev Cubana Angiol y Cir Vasc. 2015 [acceso 30/01/2020];16(1):64-75. Disponible en: http://scielo.sld.cu/pdf/ang/v16n1/ang09115.pdf

18. Hernández P, Artaza H, Díaz AJ, Cortina LD, Lam RM, Pol N, et al. Autotrasplante de células madre adultas en miembros inferiores con isquemia crítica. Rev Esp Invest Quir. 2007;10(4):204-11.

19. Dachun X, Jue L, Liling Z, Yawei X, Dayi H, Jerez L, et al. Sensibilidad y especificidad del índice tobillo-brazo para diagnosticar la enfermedad arterial periférica: una revisión estructurada. Vascular Medicine. 2010;15(5): 361-9. DOI http://dx.doi.org/10.1177/1358863X10378376

20. Velescu A, Clara A, Peñafiel J, Ramos R, Marti R, Grau M, et al. REGICOR Study Group. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study. Atherosclerosis. 2015;241:357-63. DOI: http://dx.doi.org/10.1016/j.atherosclerosis.2015.05.017

21. Tziomalos K, Giampatzis V, Bouziana S, Pavlidis A, Spanou M, Papadopoulou M, et al. Predictive value of the ankle brachial index in patients with acute ischemic stroke. Vasa. 2014;43:55-61. DOI: http://dx.doi.org/10.1024/0301-1526/a000328